TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT05832086: Intermittent Fasting Using a Fasting-Mimicking Diet to Improve Prostate Cancer Control and Metabolic Outcomes

Sponsor: Stephen Freedland · Phase: PHASE2 · Area: ONCOLOGY · Target Enrollment: 138 pts

Competing Trials Overlap

4 Active Trials

Excess Burn Exposure

$14,784,000

Rescue Site Savings

+$9,748,200

Unlock Full NCT05832086 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT05832086 Rescue Dossier →